Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
A biosimilar is a biological product that is very similar to a reference biologic and for which there are no clinically meaningful differences in terms of safety, purity, and potency.
This report elaborates on the current development of the Biosimilar industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Celltrion
BIOCAD
Pfizer
Biocon
Coherus BioSciences
Novartis
Genor BioPharma
Intas Pharmaceuticals Limited
Allergan plc
Boehringer Ingelheim
Reliance Life Sciences
By Type:
Human Growth Hormones
Erythropoietin
Monoclonal Antibodies
Insulin
Peptides
By Application:
Growth Hormone Deficiency
Chronic and Autoimmune Diseases
Others
Infectious Diseases
Oncology
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Biosimilar Market Overview 2018-2029
-
1.1 China Biosimilar Industry Development Overview
-
1.2 China Biosimilar Industry Development History
-
1.3 China Biosimilar Industry Market Size (2018-2029)
-
1.4 China Biosimilar Market Analysis by Type from Production Side
-
1.4.1 China Biosimilar Production Volume, Production Value and Growth Rate of Human Growth Hormones (2018-2029)
-
1.4.2 China Biosimilar Production Volume, Production Value and Growth Rate of Erythropoietin (2018-2029)
-
1.4.3 China Biosimilar Production Volume, Production Value and Growth Rate of Monoclonal Antibodies (2018-2029)
-
1.4.4 China Biosimilar Production Volume, Production Value and Growth Rate of Insulin (2018-2029)
-
1.4.5 China Biosimilar Production Volume, Production Value and Growth Rate of Peptides (2018-2029)
-
1.5 China Biosimilar Market Analysis by Application from Consumption End
-
1.5.1 China Biosimilar Sales Volume, Sales Value and Growth Rate of Growth Hormone Deficiency (2018-2029)
-
1.5.2 China Biosimilar Sales Volume, Sales Value and Growth Rate of Chronic and Autoimmune Diseases (2018-2029)
-
1.5.3 China Biosimilar Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.5.4 China Biosimilar Sales Volume, Sales Value and Growth Rate of Infectious Diseases (2018-2029)
-
1.5.5 China Biosimilar Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)
-
1.6 China Biosimilar Market Analysis by Region
-
1.6.1 North China Biosimilar Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Biosimilar Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Biosimilar Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Biosimilar Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Biosimilar Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Biosimilar Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Biosimilar Market Size and Growth Rate from 2018-2029
Chapter 2 China Biosimilar Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Biosimilar Market Status and Competition at home and abroad in 2023
-
2.2.2 China Biosimilar Market Status and Competition Analysis in 2023
-
2.2.3 China Biosimilar Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Biosimilar Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Biosimilar Industry Development
Chapter 3 BiosimilarIndustry Chain Analysis
-
3.1 Biosimilar Industry Chain
-
3.2 Biosimilar Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Biosimilar Market
-
3.3 Biosimilar Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Biosimilar Market
Chapter 4 China Biosimilar Market, by Type
-
4.1 China Biosimilar Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Biosimilar Total Production Volume and Growth Rate from Production Side
-
4.5 China Biosimilar Production Volume and Growth Rate, by Type
-
4.5.1 China Biosimilar Production Volume and Growth Rate of Human Growth Hormones
-
4.5.2 China Biosimilar Production Volume and Growth Rate of Erythropoietin
-
4.5.3 China Biosimilar Production Volume and Growth Rate of Monoclonal Antibodies
-
4.5.4 China Biosimilar Production Volume and Growth Rate of Insulin
-
4.5.5 China Biosimilar Production Volume and Growth Rate of Peptides
Chapter 5 China Biosimilar Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Biosimilar Total Market Size and Growth Rate from Consumption End
-
5.5 China Biosimilar Market Size and Growth Rate, by Application
-
5.5.1 China Biosimilar Market Size and Growth Rate of Growth Hormone Deficiency
-
5.5.2 China Biosimilar Market Size and Growth Rate of Chronic and Autoimmune Diseases
-
5.5.3 China Biosimilar Market Size and Growth Rate of Others
-
5.5.4 China Biosimilar Market Size and Growth Rate of Infectious Diseases
-
5.5.5 China Biosimilar Market Size and Growth Rate of Oncology
Chapter 6 China Biosimilar Market, by Region
-
6.1 China Biosimilar Production Volume and Production Value, by Region
-
6.2 China Biosimilar Sales Volume and Sales Value, by Region
Chapter 7 North China Biosimilar Market Analysis
-
7.1 North China Biosimilar Market, by Type
-
7.2 North China Biosimilar Market, by Application
Chapter 8 Central China Biosimilar Market Analysis
-
8.1 Central China Biosimilar Market, by Type
-
8.2 Central China Biosimilar Market, by Application
Chapter 9 South China Biosimilar Market Analysis
-
9.1 South China Biosimilar Market, by Type
-
9.2 South China Biosimilar Market, by Application
Chapter 10 East China Biosimilar Market Analysis
-
10.1 East China Biosimilar Market, by Type
-
10.2 East China Biosimilar Market, by Application
Chapter 11 Northeast China Biosimilar Market Analysis
-
11.1 Northeast China Biosimilar Market, by Type
-
11.2 Northeast China Biosimilar Market, by Application
Chapter 12 Southwest China Biosimilar Market Analysis
-
12.1 Southwest China Biosimilar Market, by Type
-
12.2 Southwest China Biosimilar Market, by Application
Chapter 13 Northwest China Biosimilar Market Analysis
-
13.1 Northwest China Biosimilar Market, by Type
-
13.2 Northwest China Biosimilar Market, by Application
Chapter 14 Company Profiles
-
14.1 Celltrion
-
14.1.1 Celltrion Company Profile
-
14.1.2 Celltrion Biosimilar Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 BIOCAD
-
14.2.1 BIOCAD Company Profile
-
14.2.2 BIOCAD Biosimilar Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Pfizer
-
14.3.1 Pfizer Company Profile
-
14.3.2 Pfizer Biosimilar Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Biocon
-
14.4.1 Biocon Company Profile
-
14.4.2 Biocon Biosimilar Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Coherus BioSciences
-
14.5.1 Coherus BioSciences Company Profile
-
14.5.2 Coherus BioSciences Biosimilar Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Novartis
-
14.6.1 Novartis Company Profile
-
14.6.2 Novartis Biosimilar Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Genor BioPharma
-
14.7.1 Genor BioPharma Company Profile
-
14.7.2 Genor BioPharma Biosimilar Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Intas Pharmaceuticals Limited
-
14.8.1 Intas Pharmaceuticals Limited Company Profile
-
14.8.2 Intas Pharmaceuticals Limited Biosimilar Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Allergan plc
-
14.9.1 Allergan plc Company Profile
-
14.9.2 Allergan plc Biosimilar Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Boehringer Ingelheim
-
14.10.1 Boehringer Ingelheim Company Profile
-
14.10.2 Boehringer Ingelheim Biosimilar Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Reliance Life Sciences
-
14.11.1 Reliance Life Sciences Company Profile
-
14.11.2 Reliance Life Sciences Biosimilar Market Performance
-
14.11.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Biosimilar Industry Research Conclusions
-
15.2 Biosimilar Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Biosimilar Industry Market Size (2018-2029)
-
Figure China Biosimilar Production Volume, Production Value and Growth Rate of Human Growth Hormones (2018-2029)
-
Figure China Biosimilar Production Volume, Production Value and Growth Rate of Erythropoietin (2018-2029)
-
Figure China Biosimilar Production Volume, Production Value and Growth Rate of Monoclonal Antibodies (2018-2029)
-
Figure China Biosimilar Production Volume, Production Value and Growth Rate of Insulin (2018-2029)
-
Figure China Biosimilar Production Volume, Production Value and Growth Rate of Peptides (2018-2029)
-
Figure China Biosimilar Sales Volume, Sales Value and Growth Rate of Growth Hormone Deficiency (2018-2029)
-
Figure China Biosimilar Sales Volume, Sales Value and Growth Rate of Chronic and Autoimmune Diseases (2018-2029)
-
Figure China Biosimilar Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure China Biosimilar Sales Volume, Sales Value and Growth Rate of Infectious Diseases (2018-2029)
-
Figure China Biosimilar Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)
-
Figure North China Biosimilar Market Size and Growth Rate from 2018-2029
-
Figure Central China Biosimilar Market Size and Growth Rate from 2018-2029
-
Figure South China Biosimilar Market Size and Growth Rate from 2018-2029
-
Figure East China Biosimilar Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Biosimilar Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Biosimilar Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Biosimilar Market Size and Growth Rate from 2018-2029
-
Figure Biosimilar Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Biosimilar Market Share by Type in 2018
-
Figure China Biosimilar Market Share by Type in 2023
-
Figure China Biosimilar Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Biosimilar Production Volume and Growth Rate of Human Growth Hormones (2018-2023)
-
Figure China Biosimilar Production Volume and Growth Rate of Erythropoietin (2018-2023)
-
Figure China Biosimilar Production Volume and Growth Rate of Monoclonal Antibodies (2018-2023)
-
Figure China Biosimilar Production Volume and Growth Rate of Insulin (2018-2023)
-
Figure China Biosimilar Production Volume and Growth Rate of Peptides (2018-2023)
-
Figure China Biosimilar Market Share by Application in 2018
-
Figure China Biosimilar Market Share by Application in 2023
-
Figure China Biosimilar Total Market Size and Growth Rate from Consumption End
-
Figure China Biosimilar Market Size and Growth Rate of Growth Hormone Deficiency (2018-2023)
-
Figure China Biosimilar Market Size and Growth Rate of Chronic and Autoimmune Diseases (2018-2023)
-
Figure China Biosimilar Market Size and Growth Rate of Others (2018-2023)
-
Figure China Biosimilar Market Size and Growth Rate of Infectious Diseases (2018-2023)
-
Figure China Biosimilar Market Size and Growth Rate of Oncology (2018-2023)
-
Table China Biosimilar Production Volume by Region (2018-2023)
-
Table China Biosimilar Production Volume Share by Region (2018-2023)
-
Figure China Biosimilar Production Volume Share by Region (2018-2023)
-
Table China Biosimilar Production Value by Region (2018-2023)
-
Table China Biosimilar Production Value Share by Region (2018-2023)
-
Figure China Biosimilar Production Value Share by Region (2018-2023)
-
Table China Biosimilar Sales Volume by Region (2018-2023)
-
Table China Biosimilar Sales Volume Share by Region (2018-2023)
-
Figure China Biosimilar Sales Volume Share by Region (2018-2023)
-
Table China Biosimilar Sales Value by Region (2018-2023)
-
Table China Biosimilar Sales Value Share by Region (2018-2023)
-
Figure China Biosimilar Sales Value Share by Region (2018-2023)
-
Table North China Biosimilar Production Volume by Type (2018-2023)
-
Table North China Biosimilar Production Volume Share by Type (2018-2023)
-
Figure North China Biosimilar Production Volume Share by Type (2018-2023)
-
Table North China Biosimilar Sales Volume by Application (2018-2023)
-
Table North China Biosimilar Sales Volume Share by Application (2018-2023)
-
Figure North China Biosimilar Sales Volume Share by Application (2018-2023)
-
Table Central China Biosimilar Production Volume by Type (2018-2023)
-
Table Central China Biosimilar Production Volume Share by Type (2018-2023)
-
Figure Central China Biosimilar Production Volume Share by Type (2018-2023)
-
Table Central China Biosimilar Sales Volume by Application (2018-2023)
-
Table Central China Biosimilar Sales Volume Share by Application (2018-2023)
-
Figure Central China Biosimilar Sales Volume Share by Application (2018-2023)
-
Table South China Biosimilar Production Volume by Type (2018-2023)
-
Table South China Biosimilar Production Volume Share by Type (2018-2023)
-
Figure South China Biosimilar Production Volume Share by Type (2018-2023)
-
Table South China Biosimilar Sales Volume by Application (2018-2023)
-
Table South China Biosimilar Sales Volume Share by Application (2018-2023)
-
Figure South China Biosimilar Sales Volume Share by Application (2018-2023)
-
Table East China Biosimilar Production Volume by Type (2018-2023)
-
Table East China Biosimilar Production Volume Share by Type (2018-2023)
-
Figure East China Biosimilar Production Volume Share by Type (2018-2023)
-
Table East China Biosimilar Sales Volume by Application (2018-2023)
-
Table East China Biosimilar Sales Volume Share by Application (2018-2023)
-
Figure East China Biosimilar Sales Volume Share by Application (2018-2023)
-
Table Northeast China Biosimilar Production Volume by Type (2018-2023)
-
Table Northeast China Biosimilar Production Volume Share by Type (2018-2023)
-
Figure Northeast China Biosimilar Production Volume Share by Type (2018-2023)
-
Table Northeast China Biosimilar Sales Volume by Application (2018-2023)
-
Table Northeast China Biosimilar Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Biosimilar Sales Volume Share by Application (2018-2023)
-
Table Southwest China Biosimilar Production Volume by Type (2018-2023)
-
Table Southwest China Biosimilar Production Volume Share by Type (2018-2023)
-
Figure Southwest China Biosimilar Production Volume Share by Type (2018-2023)
-
Table Southwest China Biosimilar Sales Volume by Application (2018-2023)
-
Table Southwest China Biosimilar Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Biosimilar Sales Volume Share by Application (2018-2023)
-
Table Northwest China Biosimilar Production Volume by Type (2018-2023)
-
Table Northwest China Biosimilar Production Volume Share by Type (2018-2023)
-
Figure Northwest China Biosimilar Production Volume Share by Type (2018-2023)
-
Table Northwest China Biosimilar Sales Volume by Application (2018-2023)
-
Table Northwest China Biosimilar Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Biosimilar Sales Volume Share by Application (2018-2023)
-
Table Celltrion Company Profile
-
Table Celltrion Biosimilar Revenue, Price and Gross (2018-2023)
-
Table BIOCAD Company Profile
-
Table BIOCAD Biosimilar Revenue, Price and Gross (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Biosimilar Revenue, Price and Gross (2018-2023)
-
Table Biocon Company Profile
-
Table Biocon Biosimilar Revenue, Price and Gross (2018-2023)
-
Table Coherus BioSciences Company Profile
-
Table Coherus BioSciences Biosimilar Revenue, Price and Gross (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Biosimilar Revenue, Price and Gross (2018-2023)
-
Table Genor BioPharma Company Profile
-
Table Genor BioPharma Biosimilar Revenue, Price and Gross (2018-2023)
-
Table Intas Pharmaceuticals Limited Company Profile
-
Table Intas Pharmaceuticals Limited Biosimilar Revenue, Price and Gross (2018-2023)
-
Table Allergan plc Company Profile
-
Table Allergan plc Biosimilar Revenue, Price and Gross (2018-2023)
-
Table Boehringer Ingelheim Company Profile
-
Table Boehringer Ingelheim Biosimilar Revenue, Price and Gross (2018-2023)
-
Table Reliance Life Sciences Company Profile
-
Table Reliance Life Sciences Biosimilar Revenue, Price and Gross (2018-2023)
-
